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Abstract
Practice Problem: Alcohol Use Disorders (AUD) affects a significant portion of the population
in the United States. When AUD is either unrecognized or inadequately treated in the acute care
setting it can lead to medical complications, increased length or stay (LOS), increased healthcare
expense, and increased patient mortality.
PICOT: In a population of adult patients admitted to an acute care hospital progressive care unit
(P), how does applying an initial evidence-based screening tool to detect risk for moderate to
severe alcohol withdrawal, the PAWSS (I), compare to no standard screening or assessment for
potential alcohol withdrawal symptoms (C) affect the occurrence of patient deterioration for
acute alcohol withdrawal symptoms (O) within an eight week timeframe (T)?
Evidence: The primary research articles included resulted in Level II grade criteria according to
the Johns Hopkins EBP Model rating hierarchy. The PAWSS tool was supported as both a
reliable and valid predictive measure of risk for developing AWS in the acute care setting.
Intervention: The PAWSS tool was utilized to screen all patients admitted to the progressive
care unit. Patients identified at moderate to severe risk by a score of ≥4 were treated according to
the standard facility practice with included CIWA-Ar monitoring and medication management
with benzodiazepine medication.
Outcome: The project was able to demonstrate a significant decrease in the mean LOS for those
patients identified at risk and treated for AWS, with an average decrease of 50 hours in length of
stay for those patients treated during the project implementation.
Conclusion: Early recognition of patients at risk for AWS is an important component of
effective management and treatment. Further study is needed into best practices for treatment of
patients at risk, and internal compliance measures within the organization.
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Implementing an Evidence-Based Practice Change for Alcohol Withdrawal in an Acute
Care Hospital
Alcohol Use Disorders (AUD) create a significant impact on mortality and medical comorbidity in the United States. According to the Centers for Disease Control and Prevention
(CDC), the excessive use of alcohol is responsible for approximately 95,000 deaths annually, and
in 2010 created more than $249 billion in economic costs (CDC, 2020). The development of
more effective preventative recognition and pharmacotherapies to treat the disease of AUD is a
global health concern. Early recognition of the presence of an AUD in acute hospital care
settings and identifying risk for withdrawal by evidence-based practice interventions can help
improve patient care and outcomes. This DNP project will discuss the implementation of an
evidence-based practice change utilizing the Prediction of Alcohol Withdrawal Severity Scale
(PAWSS) to detect acute risk for moderate to severe alcohol withdrawal in the acute care setting.
The PAWSS can be used as a screening tool for risk to predict the need for other standard
monitoring methods already used in AWS treatment such as the use of the Clinical Institute
Withdrawal Assessment for Alcohol-revised version (CIWA-Ar) or use of medication-assisted
treatments. Implementation of early risk assessment is one factor that will ultimately improve
outcomes for patients with AUD, including those patients who are at risk for moderate to severe
symptoms of Alcohol Withdrawal Syndrome (AWS) in acute care hospital settings.
Significance of the Practice Problem
Alcohol Use Disorder is a global public health problem that continues to significantly
impact the population in the United States (Xierali et al, 2021). The World Health Organization
Global Information Systems on Alcohol and Health estimates that on an annual basis alcohol
consumption results in the death of 3 million people globally and is associated with 230 different
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types of diseases (World Health Organization, 2016). AUD and the excessive use of alcohol have
been identified as leading causes of preventable death in the United States (Esser et al., 2020).
AUD is estimated to affect 12.7% of the population in the United States, with a projected twofold increase anticipated following the COVID-19 pandemic (Da, Im & Schiano, 2020).
Excessive drinking accounts for approximately 1 in 10 deaths among working-age adults in the
United States (Stahre et al., 2014). In the state of California, excessive alcohol use is estimated to
cost more than $35 million annually in 2015 due to loss of workplace productivity, health care
expenses, and other costs related to criminal justice expenses, car accidents, and property
damage (CDC, 2015). For individuals arrested in San Diego County in 2018, 43% of males and
27% of females reported drinking within the last 24 hours (Burke, 2019). There is also early
evidence that the COVID-19 pandemic has increased alcohol consumption in the United States,
putting more people at risk for potential adverse health effects (Capasso et al., 2021).
Alcohol consumption has been linked to an increased burden of disease and mortality for
several health conditions (Rehm et al., 2017). For patients undergoing elective surgery, acute
alcohol withdrawal was associated with perioperative complications, 40% higher overall cost of
treatment, and 85% longer length of stay (Lin et al., 2017). Chernyavsky et al. (2020) estimate in
the United States that more than 20% of patients admitted to the acute care hospital setting meet
the criteria for AUD and that more than 2 million patients experience withdrawal symptoms each
year. The percentage of patients admitted to the hospital for medical issues other than AUD who
experience alcohol withdrawal can be as high as 42% in veteran populations (Shu, Lin & Chang,
2015).
For those patients with AUD, there is an increased risk for AWS when alcohol is abruptly
discontinued, as is the case for those patients admitted to an acute care hospital for treatment of a
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medical condition (Sukhenko, 2015). Complications of withdrawal can include mild symptoms
like nausea, vomiting, or increased blood pressure (Trevisan et al., 1998). Up to 20% of patients
with acute alcohol withdrawal develop severe symptoms associated with complicated AWS,
including delirium tremens and withdrawal seizures (Maldonado et al., 2010) or Wernicke
encephalopathy (Ostrovsky, 2018). For those patients that do experience these more severe
complications, up to 20% may ultimately die from these complications compounded by other
medical comorbidities (Campos et al., 2011).
PICOT Question
The PICOT question addresses the relationship between a population (P), intervention (I),
comparison (C), outcome (O) and time (T). This project poses the question in a population of
adult patients admitted to an acute care hospital progressive care unit (P), how does applying an
initial evidence-based screening tool to detect risk for moderate to severe alcohol withdrawal, the
PAWSS (I), compare to no standard screening or assessment for potential alcohol withdrawal
symptoms (C) affect the occurrence of patient deterioration for acute alcohol withdrawal
symptoms (O) within an eight week timeframe (T)? The population will include all adult patients
admitted to the progressive care unit in an acute care hospital. The intervention would be the
application of the PAWSS at the time of admission to the unit. The comparison would be the
current practice of no standard assessment at the time of admission for risk for alcohol
withdrawal. The outcome of patient deterioration would be defined by indicators of severe
alcohol withdrawal including the need for rapid response, CIWA-Ar scores increased over mild
range indicated by a score of greater than 15, “code green” security personnel response for
patient behavioral deterioration, or symptoms requiring a higher level of care or ICU transfer.
The timeframe would be eight weeks.
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Evidence-Based Practice Framework & Change Theory
This project utilized the John’s Hopkins Evidence-Based Practice (EBP) model to
describe the practice change. The John Hopkins Nursing EBP model follows a three-step process
for practice change: practice question, evidence, translation (Dang & Dearholt, 2018). The goal
of this model is to incorporate the latest research findings and best practices into patient care in a
manner that efficient and appropriate (Dang & Dearholt, 2018). This model starts with
generating a practice question, then evaluates evidence to support practice change, and finally
translates the evidence into practice change.
This change project utilized Lewin’s Change Theory to facilitate practice change.
According to Lewin’s Change Theory as it is applied to nursing practice, “change occurs in three
stages: unfreezing, moving and refreezing” (Lee, 2006, p. 489). Specific strategies are needed at
each stage of change to continue to facilitate the change process. This theory was a good fit to
address practice change for implementing an alcohol withdrawal assessment tool because it was
easily applied to evidence-based practice change (Manchester et al., 2014). In the initial
unfreezing stage, evidence-based practice change was identified and stakeholder buy-in helped
drive momentum for the practice change. The project manager helped develop an awareness of
the significance of the practice problem and the gaps within the current organizational practices.
Additionally, the project manager helped to identify nurse champions to keep change momentum
progressing during the “moving” stage. During the moving phase, the project manager, along
with key stakeholders in the process, implemented the change in practice. Throughout this
“moving” stage, staff were educated and encouraged to implement the change to drive better
patient outcomes. During the “refreezing” stage, the change continues to be reinforced. This
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included organizational and environmental changes to sustain the change, and recommendations
to include other techniques like periodic auditing to cement the practice change.
Evidence Search Strategy
To gain an initial understanding of the scope and depth of the problem, as well as to
become more familiar with some of the current literature trends and key relevant search terms,
initial literature searches were conducted via databases such as the Cochrane Database of
Systemic Reviews (CDSR), PubMed, Cumulative Index to Nursing and Allied Health Literature
(CINAHL) complete and APA PsychINFO database search as well as Google Scholar website.
Some of the terms searched in different combinations included inclusion criteria of the terms:
alcohol withdrawal syndrome, AWS, alcohol withdrawal assessment, and acute care, clinical
assessment, and acute alcohol withdrawal. Articles that were systematic reviews or metaanalyses were identified within the literature review were also examined to help further define
search criteria and potential exclusions. Medical Subject Headings (MeSh) terms of “Alcohol
Withdrawal Syndrome” and “Clinical Assessment” were utilized also as inclusion criteria. These
searches resulted in over 2200 articles from the 2010 to 2021 timeframe.
Exclusion criteria were developed to attempt to eliminate research content related to
emergency department or ICU care setting, mental health settings, studies primarily focused on
medication management strategies, pediatric population, articles focused on animal populations,
and articles not written in the English language. The abstracts were reviewed for exclusion
criteria and those articles that met the inclusion criteria for relevance to the PICOT question were
full-text reviewed. A total of 48 articles were included for full-text review and 26 articles were
included in the final synthesis of the literature.
Evidence Search Results
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To understand and define AUD, understand AWS, and evaluate the evidence-based
recommendations for assessment and treatment of the disorder, a comprehensive literature
review was conducted. Initial search results were outlined according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) model as discussed above (See
Figure 1 for PRISMA model). Of these, four articles were identified as primary research related
to the PICOT question (see Appendix A) and four were identified from systematic reviews as
relevant to the PICOT question (See Appendix B).
Those articles included as primary research were graded according to the Johns Hopkins
EBP Model rating hierarchy for the level of research evidence (Dang & Dearholt, 2018). All of
the primary research articles included resulted in Level II grade criteria of research (Griessbach
et al., 2019; Mahabir et al., 2020; Maldonado et al., 2015; Padron, 2019). One study was a
retrospective analysis design (Griessbach et al., 2019), while the others were quasi-experimental
designs. Due to the nature of AUD and AWS, there were no primary research studies identified
in the literature that would allow for randomized control studies (RCTs) which would allow for
Level I research evidence.
Those articles included in the systematic review and meta-analysis were narrowed down
to represent those related to predicting the development of AWS and Severe Alcohol Withdrawal
Syndrome (SAWS). There were two articles with Level I quality data (Hlleck, Merchant &
Gunderson, 2019; Pribek et al., 2021) and another two with Level II quality data (Goodson,
Clark & Douglas, 2014; Maldonado et al., 2014) according to the John Hopkins EBP Model
rating hierarchy for the level of research evidence (Dang & Dearholt, 2018). (See Appendix B).
These systematic reviews related directly to the assessment of risk for developing AWS or
SAWS.
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Themes with Practice Recommendations
Understanding the Population
Multiple studies have shown that patients who have an Alcohol Use Disorder (AUD)
diagnosis, pre-existing their admission to an acute care hospital, are at increased risk for
developing complications from AWS, including potentially death (Maldonado et al., 2014, Shu
et al., 2015; Sukhenko, 2015). Chernyavsky et al. (2020) estimate in the United States that more
than 20% of patients admitted to the acute care hospital setting meet the criteria for AUD and
that more than 2 million patients experience withdrawal each year. The percentage of patients
admitted for medical issues other than AUD who experience alcohol withdrawal can be as high
as 42% in veteran populations (Shu, Lin & Chang, 2015). Maldonado, et al. (2014), estimated
only 7% of physicians correctly identify patients at risk for complicated AWS in the acute care
setting. Additionally, studies support that no one factor is predictive of severe alcohol
withdrawal (Goodson, Clark, & Douglas, 2014; Burkhardt et al., 2020; Rosoff et al., 2020).
Evidence-Based Treatment for Patients at Risk for Acute Alcohol Withdrawal Syndrome
Most assessment and treatment strategies for AWS are based on the understanding of the
physiology of withdrawal (Maldonado et al., 2014). The ingestion of alcohol has an inhibitory
effect on the N-methyl-D-aspartate (NMDA) receptors in the central nervous system and an
agonistic effect on gamma-aminobutyric acid type-A (GABAA) receptors within the central
nervous system (Dixit et al., 2016; Haass-Koffler, Cannella & Ciccocioppo, 2020). Over time,
the continued exposure to alcohol leads to tolerance in the central nervous system, reflected in
the NMDA receptors being up-regulated while the GABAA receptors are down-regulated
(McKeon, Frye, & Delanty, 2008). When the alcohol exposure in the central nervous system is
abruptly decreased or eliminated, these roles are reversed, leading to “dopaminergic
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dysregulation” and producing the signs and symptoms of AWS (Sykhenko, 2015). Generally,
AWS is made up of a cluster of symptoms resulting from this dopaminergic dysregulation.
Symptoms (See Table 1 for the stages of AWS) usually develop within 24-48 hours after last use
including tachycardia, diaphoresis, tremors, irritability, agitation, hypertension, seizures, and
sometimes delirium or hallucinations in the later stages (Holt et al., 2016; Ostrovsky, 2018). Not
all patients experience all stages, nor do they progress sequentially through them, making
recognition of the potential for AWS and ongoing monitoring for those at risk essential in the
appropriate management of alcohol withdrawal (Lindsay et al., 2020; Maldonado et al., 2014;
Monte et al., 2010).
Evidence-Based Screening for Risk Assessment
While assessment for alcohol withdrawal was previously relegated to those patients
displaying risk factors of alcohol abuse, more evidence has shown that routine screening of
patients for risk for alcohol withdrawal is more effective than just relying on clinical judgment
(Keys, 2011; Maldonado et al., 2014; Sutton & Jutel, 2016). The Clinical Institute Withdrawal
Assessment for Alcohol-Revised (CIWA-Ar) has been the most widely researched tool;
however, despite its prevalent use, the CIWA-Ar has shown to be inconsistent in its ability to
correctly identify patients needing intervention for withdrawal (Hecksel et al, 2008; Holleck et
al., 2019; Pribék et al., 2021) In fact, Hecksel et al. (2008) reported that as many as 64% of
patients on CIWA-Ar monitoring may be incorrectly identified as needing medication. One of
the major critiques of this tool has been its moderate performance at predicting severe alcohol
withdrawal (Eloma et al., 2018) presumably because it was designed as a monitoring tool, not a
predictive assessment tool.
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The Alcohol Withdrawal Triage Tool (AWTT) (Mahabir et al., 2020) is comprised of a
complicated set of independent predictors of risk for AWS that need to be gathered from the
medical record. The AWTT showed some potential to identify patients at risk for severe AWS,
but the validation dataset “resulted in a c-statistic pf 0.786” which was not sufficient to support
this as a stand-alone tool (Mahabir et al., 2020, p. 5). The Alcohol Withdrawal Assessment Tool
(AWAT) was developed as a shorter version of the CIWA-Ar that took into account some of the
physiological symptoms of alcohol withdrawal and had 4 questions related to pulse/blood
pressure, agitation/tremors, confusion/hallucination, and diaphoresis (Davis et al., 2018). While
the AWAT is one of only a few tools that was tested in the acute care setting, the AWAT was
only tested with a small sample size (n=51), and the predictability was compared against the
CIWA-Ar which as discussed was not designed to predict risk for alcohol withdrawal. The
Luebeck Alcohol withdrawal Risk Scale (LARS) was also developed to predict the severity of
withdrawal and has been validated in psychiatric settings (Wetterline et al., 2006). However,
there was no evidence of validation for the tool within the acute care hospital setting.
The Prediction of Alcohol Withdrawal Severity Scale (PAWSS) has been both studied
and validated in the acute care hospital setting (Maldonado et. al., 2014) for its predictive
validity in identifying patients at risk for severe alcohol withdrawal (Maldonado et al., 2015;
Padron & Salzman, 2019). See Appendix A. The PAWSS tool research was graded according to
the Johns Hopkins EBP Model rating hierarchy for the level of research evidence (Dang &
Dearholt, 2018) and was graded Level II primary research, due to strong predictive validity
(Maldonado et al, 2015) with a Positive Predictive Validity of 93.1% (95%CI), and Negative
Predictive Validity of 99.5% (95%CI). The PAWSS lacks randomized controlled trials, which
was anticipated given the nature of the tool. The PAWSS is an open-source tool that does not
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require permission to use. The application of this assessment tool has not been shown to have
any potential risks for the patient population as it can be incorporated into the standard admission
assessment.
Practice Recommendation
The evidence-based practice recommendation for patients admitted to an acute care
hospital unit was to utilize the PAWSS to screen and predict risk for severe alcohol withdrawal.
By standardizing the risk assessment tool, the facility would be able to more accurately identify
those patients at risk for moderate to severe AWS. Those patients identified at moderate to
severe risk by a score of ≥4 would be treated according to the standard facility practice which
included utilizing the CIWA-Ar (see Appendix H) to monitor for current alcohol withdrawal
symptoms and to treat the patient according to the current standard practice which included
symptom-based benzodiazepine medication or fixed-dose dependent on the physician orders.
The early and accurate identification of those patients at risk for AWS would support appropriate
treatment recommendations to minimize the risk for patient deterioration from unrecognized
AWS.
Setting, Stakeholders, and Systems Change
The Southern California setting identified for this evidence-based change project was in
an acute care hospital on a progressive care unit. The mission of the organization was to improve
the health of those served with a commitment to excellence in all that the organization does. The
organizational goal was to offer quality care and services that set community standards, exceed
patients' expectations, and provide care that is convenient, cost-effective, and accessible. The
organization has 524 licensed beds, with services ranging from Emergency Room Care, Medical
and Surgical ICU, Progressive Care, Oncology, Women’s Health, Physical Rehab, and

ALCOHOL WITHDRAWAL

13

Behavioral Health Services. The healthcare facility has a Magnet Designation for Nursing
Excellence®. The hospital Emergency Department (ED) serves a diverse population and
demographic area that stretches from the coast of Southern California to the Arizona border and
was in the top five percent of the nation in Emergency Room patient volume.
A SWOT analysis was conducted as part of the organization gap analysis. There was an
identified opportunity to improve patient outcomes with early recognition and treatment of AUD
(see SWOT Analysis, Appendix D). Using the Organizational Cultural Profile developed by
Groysberg et al., (2018) the organization demonstrated a change structure that reflects structural
stability and authoritative top-down leadership-driven change. This meant that key
organizational leadership needed to be supportive of the change process for it to be successful.
Key stakeholders identified included the hospital Chief Nursing Officer (CNO), the Director of
PCU, the Manager of the PCU, the Hospitalists, the Charge Nurses, the Clinical Nurse
Specialists (CNS), and front-line nurses on the progressive care unit, as well as members of the
interdisciplinary treatment team like social workers and nursing assistants, and also included the
patients.
The CNO and the Director of PCU were already aware of instances of adverse patient
outcomes and patient deterioration attributed to AWS within the acute care setting. The
cooperation of the interdisciplinary team was also essential to the successful implementation of
the evidence-based practice change. The front-line nursing staff were responsible for the
implementation of the PAWSS screening tool and communicating with the admitting physician
the need for implementation of the alcohol withdrawal order set protocol for those patients who
screened positive for risk. The CNS as well as the project manager were involved to support the
education around the new tool and to refresh the nurses' knowledge on the general treatment of
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alcohol withdrawal. The social workers were also involved for those patients that needed
connection to ongoing treatment options once they were medically stable to discharge from the
acute care setting.
The change project impacted individual patients on the micro-level by providing early
recognition and treatment of AWS within the acute care treatment setting. Providing routine
screening may have also decreased the potential patient stigma and potential bedside RN
negative bias associated with Substance Use Disorders (SUDs). This effect was not specifically
measured during this project but is a focus of ongoing assessment at the organization. On the
meso level, the families of patients receiving treatment are affected by the patient's SUD and
may have received greater support once the disorder was acknowledged, and may have sought
help to improve their own social supports (Church et al., 2018). On the macro level, providing
early recognition and interventions for a chronically undertreated or marginalized medical
condition such as SUDs has been shown to improve the overall health of the community.
Additionally, providing proactive treatment may continue to draw larger attention and support
for the treatment of marginalized disorders and increase awareness of the mental health parity
laws.
Implementation Plan with Timeline and Budget
The construction of a PICOT question, extensive literature review, and practice
recommendation formed the foundation for the evidence-based practice change proposal. This
foundation was based on the John Hopkins Nursing EBP model that follows a three-step process
for practice change: practice question, evidence, and translation. The implementation plan for
the EBP change proposal included identifying key project objectives, outlining SMART goals,
and finally the application of the change model. These goals had to be accomplished within a
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reasonable timeline for the project to be successful (see Appendix I for Project Goals and
Implementation Strategy, and Appendix D for the Project Timeline).
The first objective of the project proposal was to complete a SWOT analysis of the
organization and identify an area for practice change within the first four weeks of the NUR7801
class (see Appendix C SWOT Analysis). This formed the foundation for generating a PICOT
question and completing a literature review with practice recommendations. The next objective
was to identify key stakeholders and gain buy-in for the project. This goal is measured by the
stakeholders identified. The goal was accomplished by demonstrated buy-in of the unit and staff,
and key stakeholders identified including the hospital CNO, the Director of PCU, the Unit
Manager, the CNS, and hospital informaticist within the first 12 weeks of NUR7801. Once the
PICOT question was refined, the literature review was completed, and a practice
recommendation was generated. The practice change recommendation was to implement the
PAWSS predictive risk assessment at the time of admission to the acute care PCU (see Appendix
G for the PAWSS tool). A potential budget was also developed at this stage as it is part of the
final approval process for the healthcare organization. The only associated expenses for the
project were under $50 for paper supplies to provide the PAWSS assessment tool to the unit,
which was incorporated into the existing unit budget, and the CNS/nurse educator time
(approximately 10 hours X $60/hr = $600) to help with unit staff training and audits for
compliance during the eight weeks of implementation. Since these tasks were incorporated into
the CNS regular unit responsibilities, it did not end up creating any additional cost to the
organization. The project had the potential to decrease costs to the organization due to decreasing
length of stay or need for a higher level of care, however, these specific monetary calculations
were outside of the scope of this project. The department manager reviewed and approved the
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potential budget. The work done to define the problem and propose an evidence-based change
aligns with the “unfreezing” stage of Lewin’s change theory. It was essential to develop an
awareness of the problem and foster motivation for change.
The next portion of the change project timeline consisted of components in Lewin’s
Change Theory’s second stage; the “moving” stage. Primary objectives during this stage
included gaining approval for the project implementation from the DNP program and healthcare
organization within the first three weeks of NUR7802 (see Appendix D). The University’s
approval was gained through the EBP Project Review Council (EPRC) process. The facility
approval was gained by first submitting the project proposal to the entity-based IRB
representative as a project proposal, then once it was determined that the project proposal was
EBP not research then the proposal was submitted to the Innovations and Professional
Excellence Committee for final approval. A primary reviewer was assigned and requested that an
additional flyer detailing the project information to be generated and provided to patients
agreeing to be screened with the PAWSS tool. Additionally, the request for data from the EMR
needed to be submitted to the organization informatics department, rather than allowing the
project manager to collect data directly. This was to ensure that all patient identifiers were
removed prior to data analysis.
After gaining both university and facility approval for EBP project, the next stage was the
implementation of the educational/training for the unit staff on the PAWSS tool and reinforcing
the healthcare facility protocol for the monitoring and treatment of alcohol withdrawal (See
Appendix I for Project Goals and Implementation Strategy). The final component of the
“moving” stage of change was the implementation of the screening tool on the unit for the eight
week intervention period and monitoring for compliance.
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During the final stage of Lewin’s Change Theory, the “refreezing” stage the focus was on
sustaining the practice change. During this stage, the project data was analyzed while impact and
practice implications were shared with the key stakeholders. During the “refreezing” stage, the
key stakeholders including the Unit Manager, front-line nurses, and the interdisciplinary team
took over ownership of sustaining the change process. During the “refreezing” stage, the unit
CNS took on the responsibility to continue to perform chart audits to identify any reverting to
prior behaviors of not completing the PAWSS screening. Re-education and reinforcement of the
application of the PAWSS will be offered by the CNS to sustain practice change. There was a
recommendation to “hardwire” the assessment into the electronic medical record however the
organization is in the process of changing EMR systems. There was reluctance to spend money
to incorporate this assessment tool in the old EMR; however, there is an opportunity to
incorporate this practice change in the design of the new EMR, which would support
“refreezing” of this practice change.
The EBP change project implementation required a project manager to keep the project
on track. This role required the DNP student project manager to be clear and consistent in setting
project goals. The project manager was also responsible for gaining key stakeholder buy-in and
delegating tasks like nursing education to the unit clinical nurse specialists. The project manager
also developed key partnerships with information technology staff to assist with data collection
and validation during and following the project implementation. The project manager was
responsible for the analysis of the project results and disseminating the findings, clinical
significance and future practice considerations to the key stakeholders.
Results
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In the PICOT question, the outcome reflecting patient deterioration were defined by
indicators of the need for rapid response, CIWA-Ar scores increased over mild range, code green
security personnel response for behavioral deterioration, or symptoms requiring a higher level of
care or ICU transfer. The literature demonstrates the absence of effective AWS recognition and
treatment has resulted in the need for rapid response, transfers to a higher level of care, and
longer length of stay (Holt et al., 2016; Maldonado et al., 2014; Muzyk et al., 2017) which
supports face validity for these measures. Pinkhasov et al. (2020) report AWS was associated
with a 13-fold increase in the risk of a behavioral disturbance (95% CI, 8 to 22-fold). The need
for security to respond to behavioral disturbances has been correlated with adverse patient
outcomes and increased risk for staff and patient injury, which was identified as an important
area of concern by key stakeholders including the unit manager and CNO. The project also
measured the time interval between when the patient was admitted to the unit and when the
alcohol withdrawal order set was implemented based on the time the CIWA-Ar was initiated.
The significance of this measure was to identify when treatment may have been delayed due to
failure to recognize the risk or AWS at the time of admission.
Once EBP Project Review Council (EPRC) at the university and the entity-based IRB
committees approved the project proposal, data was collected for the eight weeks before the
implementation of the project and then again during the eight week project implementation (see
Appendix E &F for data description and data collection sheet). Paper copies of the completed
PAWSS tool were collected and stored in the nursing lead office on the unit, in a folder, not
visible to the public, and stored according to HIPAA guidelines the same as patient medical
records on the unit. They were collected by the project manager weekly for analysis, and even
though they contained no patient information, the paper copies were stored on-site, double-
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locked, and not visible to the public until the completion of the project. Upon completion of the
project, the PAWSS tools were disposed of according to hospital practice for patient data
utilizing the secure document shredding procedure. All data from the EMR was validated in
conjunction with the organization’s information technology staff, and all patient identifiers were
removed prior to inputting the data points into Microsoft Excel© for statistical analysis.
Statistical analysis was completed on a hospital computer with hospital software.
During the project implementation period, the admitting nurse attempted to screen each
patient admitted using the PAWSS tool (See Appendix G). A total of 242 patients were screened
with the PAWSS tool. Patients who were non-verbal, whose level of consciousness did not allow
them to participate in the screening, and patients who refused to participate with the PAWSS
assessment were excluded. A PAWSS assessment was completed on 60% of all patients admitted
to the unit. For patients screened, 41 patients met threshold criteria and 30 patients had a score
≥4, indicating High Risk for developing moderate to severe AWS.
During the initial eight week pre-project implementation period, a total of 38 patients
admitted to the progressive care unit required treatment for AWS, while a total of 46 patients
required treatment for AWS in the eight week project implementation period (N = 84). The
primary outcomes compared between these groups were; (1) the time interval in minutes
between admittance and ordering treatment for AWS; (2) the number of rapid response team
(RRT) incidents per patient; (3) the highest recorded scores on the CIWA-Ar instrument; (4) the
patient’s length of stay in hours; and (5) code green events. Each of these outcomes were
compared using a between subjects t-test with unequal variances assumed.
The average interval between admittance and beginning treatment for AWS was not
significantly different in the pre-EBP change assessment period (M = 304.08, SD = 739.91) and
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the post-EBP change assessment period (M = 321.39, SD = 900.51, p = 0.92). There was also no
significant difference in the number of RRT incidents between the pre-EBP change group (M =
0.342, SD = 0.71) and the post-EBP change group (M = 0.348, SD = 0.71, p = 0.97). There was
also no significant difference between the highest recorded CIWA scores in the pre-EBP change
group (M = 15.71, SD = 9.24) and the post-EBP change group (M = 16.15, SD = 10.38, p =
0.83), nor in the proportion of scores in the moderate to severe range. However, there was a
significant difference in the average length of stay between the pre-EBP change group (M =
146.97, SD = 169.97) and the post-EBP change group (M = 96.54, SD = 75.17, one-tailed p =
0.048), where patients in the post-EBP change period had a length of stay that was
approximately 50 hours shorter on average. The code green data was not able to be collected
according to the patient, only the total number of responses to the unit was able to be recorded.
During the pre-EBP project timeframe, there were eight code green events. During the post-EBP
implementation, there were 16 code green events.
Impact
A demonstrated need exists to improve the early identification and treatment of patients
at risk for complications from AWS in the acute care setting. The PAWSS represents a reliable
and valid measure of risk for patients developing complicated AWS (Maldonaldo et al., 2014;
Maldonado et al., 2015). The results for this EBP project demonstrated a statistically significant
reduction in hospital length of stay, which decreased overall healthcare costs. By providing a
timely and evidence-based practice intervention for early risk assessment, this healthcare
organization will be better positioned to provide timely quality care to its patients, while at the
same time decreasing the overall length of stay.
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The implementation of this project generated interest within hospital leadership to more
closely examine how the organization provides care to patients with substance use disorders. The
hospital leadership initiated an internal committee to further explore the established treatment
pathways, patient outcome results and to develop evidence-based practice change to address
areas of deficit. Additionally, at the unit level, the CNS is continuing to explore staff confidence
and competency in treating alcohol withdrawal following the project implementation. That study
is ongoing at this time, but shows a deepened organizational interest in both evidence-based
practices as well as treating the AUD population.
Limitations
The relatively low sample size and the short period of data collection may have made it
difficult to detect any statistical significance in the data points for the number of rapid response
events. The average interval between admittance and beginning treatment for AWS did slightly
increase in the implementation period. Although this finding is not statistically significant, it may
suggest that the PAWSS tool would be most helpful if implemented in the emergency
department prior to arrival to the unit. By waiting until the time of admission, the time interval
may have been increased. Alternatively, this slight increase in the time interval could also
suggest that patients were identified as being at risk who may have otherwise been missed. Due
to limitations in how the code green data was able to be accessed at the organization, this data
point could not be correlated for any association with patients at risk for alcohol withdrawal. The
increase in the overall number of responses may be important to continue to investigate from an
organizational perspective. For future implementation, the organization may be able to explore if
this data could be captured in a different way that could include the appropriate patient identifier
to correlate the findings.
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Although this project was in its design phase before the impact of the COVID-19
pandemic could be anticipated, it was also implemented at a particularly challenging time for the
population. Early research suggests that the pandemic has increased alcohol consumption in the
United States (Attonito, Villalba & Fontal, 2021; Wardell et al., 2020). This increase in
consumption put more patients at risk for complications of AWS during their hospital stay. At
the same time that the project was implemented, there was a nationwide shortage in
chlordiazepoxide medication, one of the main medications used by this organization in its
standard treatment for alcohol withdrawal (American Society of Health System Pharmacists,
2021). The lack of availability of this medication may have negatively impacted patient care
outcomes during this project. Additionally, the COVID-19 pandemic has also impacted nursing
training and staffing needs. It was difficult to ensure that all nurses working on the unit were
equally educated about the intervention because of the increased use of float staff and travelers.
Nurse fatigue and burnout may also impact the enthusiasm for the adoption of practice and
culture change.
Dissemination Plan
The results of the project were first shared with the project manager’s preceptor and
presented to the manager and staff of the acute care unit via the staff daily huddle meeting and a
poster presentation on the unit. Next, results were disseminated within the system’s Innovation
and Professional Excellence Committee for review and feedback. Additionally, the results from
the project were shared with hospital leadership, including the CNO, and department managers
during the monthly leadership forum.
Outside of the hospital organization, the results of the DNP project will be published in
the Scholarship and Open Access Repository (SOAR@USA) collection as a DNP student project
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manuscript. Additionally, the results could be considered for submission for publication through
peer-reviewed journals such as the Clinical Nurse Specialist: The Journal for Advanced Nursing
Practice and will be submitted for consideration to present at a professional nursing conference.
The results will be relevant to a large audience, including hospital administrators as well as frontline acute care staff. This practice change could help decrease the length of stay in this patient
population, increase patient safety, increase nurse satisfaction, increase nursing knowledge about
assessing and treating acute alcohol withdrawal and provide better community population health
practices for decreasing stigma associated with AUD treatment.
Conclusion
Early recognition of the presence of an AUD in acute hospital care settings and
identifying risk for AWS by evidence-based practice interventions can help improve patient care
and outcomes. This evidence-based project utilized the Prediction of Alcohol Withdrawal
Severity Scale (PAWSS) in conjunction with the facility’s standard practice of care using the
Clinical Institute Withdrawal Assessment for Alcohol, revised version (CIWA-Ar) for early
identification of patients at risk for AWS in an acute care hospital setting. The use of effective
early recognition strategies for AWS lowered the mean length of stay. Further investigation on
the standard practices for the treatment of AWS may further improve patient care outcomes and
contribute to the nursing practice knowledge of evidence-based practice.
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Table 1
The Stages of Alcohol Withdrawal Syndrome (Ostrovsky, 2018)
Stage of AWS

Timeframe

Common Symptoms

Stage 1: Minor
withdrawal symptoms

May occur 6-12
hours after
stopping alcohol

Common symptoms include:
tremors, insomnia, irritability, mild
agitation, anorexia, nausea,
vomiting, GI upset, tension,
anxiety, heart palpitations,
sweating, restlessness

Stage 2: Alcoholic
hallucinosis

May occur 12-24
hours after
stopping alcohol

Common symptoms include:
hallucinations (auditory, visual, or
tactile) may occur

Stage 3: Withdrawal
seizures

May occur 24-48
hours after
stopping alcohol
but may begin as
early as 2 hours
after stopping
alcohol

Common symptoms include:
usually tonic-clonic seizures

Stage 4: Alcohol
Withdrawal Delirium
(Delirium Tremens)

Usually occurs 37 days after
stopping, but can
occur at any time
up to 14 days
after last use

Common symptoms include:
hallucinations (usually visual),
disorientation, tachycardia,
hypertension, agitation,
diaphoresis, low-grade fever
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Figure 1

Screening

Identification

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) model

Records identified through database
searching University of St. Augustine
library through databases such as the
Cochrane Database of Systemic
Reviews (CDSR), PubMed, CINAHL
complete and APA PsychINFO
database
(n = 2200 )

Initial search criteria included terms for subject of
“alcohol withdrawal syndrome, AWS, alcohol
withdrawal assessment, acute care, clinical assessment,
and acute alcohol withdrawal”

Records after duplicates removed
(n = 2500 )

Records screened
(n =224 )

Eligibility

Additional records identified through
Google Scholar
(n = 1250)

Full-text articles assessed for
eligibility
(n = 48 )

Records excluded: Relating
primary to medications or
animal studies, or practice
settings outside of acute care
(n = 2276 )

Full-text articles excluded,
with reasons not related to
assessment or not in hospital
setting
(n = 22 )

Included

Studies included in
qualitative synthesis
(n =26)

Studies included in
quantitative synthesis (metaanalysis)
(n = 4 )

Note. Adapted from Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. The PRISMA Group (2009). Preferred
Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLOS Medicine, 6(7),
e1000097. https://doi.org/10.1371/journal.pmed.1000097

ALCOHOL WITHDRAWAL

35

Appendix A
Summary of Primary Research Evidence
Intervention

Citation

Design,
Level
Quality
Grade

Griessbach, A. N., Mueller, B. U., Battegay, E.,
& Beeler, P. E. (2019). The maximum Alcohol
Withdrawal Syndrome score associates with
worse clinical outcomes—A retrospective cohort
study. Drug and Alcohol Dependence, 205.
https://doi.org/10.1016/j.drugalcdep.2019.107708

Mahabir, C. A., Anderson, M., Cimino, J.,
Lyden, E., Siahpush, M., & Shiffermiller, J.
(2020). Derivation and validation of a
multivariable model, the alcohol withdrawal
triage tool (AWTT), for predicting severe

Retrospective
study

Randomized,
retrospective
analysis,
without a
control group

Sample
Sample
size

2464
hospital
stays with
19,312
AWS
assessments
were
included

2038
unique
patients

Comparison
(Definitions should
include any specific
research tools used along
with reliability &
validity)
A retrospective analysis
collected data from the
medical record from
CIWA-Ar measures along
with physiological data to
complete Wetterling scale
(11-item combination of
CIWA-Ar measures with
physiological markers).
The results from the first
three days of the stay
along with presence of
diagnosis of AWS were
grouped into “mild”(<6)
“moderate” (6-9) or
“severe” (>9) and then
correlated with hospital
outcome data

In order to study the
Alcohol Withdrawal
Triage Tool (AWTT) 8
different preditors of
severe AWS were studied

Theoretical
Foundation

Outcome
Definition

STROBE
guidelines
(STrengthening
the Reporting
of
OBservational
studies in
Epidemiology)

The authors
analyzed
potential
associations
of the
maximum
AWS score
with worse
clinical
outcomes,
i.e.,
increased
LOS and inhospital
mortality,
using
multivariable
linear and
logistic
regression,
respectively

None stated

The authors
uses
regression
analysis to
study the

Usefulness
Results
Key Findings

According to the authors
“Higher maximum AWS
scores are associated
with increased Legnth of
Stay (LOS) and inhospital mortality.
Determination of the
maximum AWS score
within 3 days after the
first assessment appears
to be sufficient and may
predict increased LOS
and in-hospital
mortality.
This may help health
care providers to
anticipate AWS
progression and in
properly preparing
short-, medium-, and
long-term care.”
The use of the 8 factors
that can be collected
from the electronic
medical record can
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Alcohol Withdrawal Syndrome. Drug and
Alcohol Dependence, 209.
https://doi.org/10.1016/j.drugalcdep.2020.107943

Maldonado, J. R., Sher, Y., Das, S., Hills-Evans,
K., Frenklach, A., Lolak, S., Talley, R., & Neri,
E. (2015). Prospective Validation Study of the
Prediction of Alcohol Withdrawal Severity Scale
(PAWSS) in Medically Ill Inpatients: A New
Scale for the Prediction of Complicated Alcohol
Withdrawal Syndrome. Alcohol &
Alcoholism, 50(5), 509–518.
https://doi.org/10.1093/alcalc/agv043

Padron, A. & Salzman, M.(2019). "PAWSS:
Validation of the Prediction of Alcohol
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with a retrospective
analysis. Patients were
randomly divided into two
cohorts: the “Derivation
cohort” and the
“Validation cohort. Within
the “derivation cohort”
908 patients were analyses
and in the “Validation
cohort” 461 patients were
analyzed

Level II

Quaziexperimental
prospective
study

403
patients

Level II

Quaziexperimental

880
patients

All patients admitted to
the hospital during the
study time that could
speak English and were
willing to participate were
screened. The patients
were also screen using the
CIWA-Ar as per the usual
hospital protocol. The
participants were followed
for three days with the
research team blinded to
results from other
assessments

Intervention: Application
of the PAWSS

relationship
between the
8 identified
predictors of
Severe
Alcohol
Withdrawal
Syndrome
(SAWS).

None stated

None stated

The primary
outcome
consisted of
the PAWSS
ability in
predicting
complicated
AWS, its
sensitivity,
specificity,
positive and
negative
predictive
values, as
well as interrater
reliability

Alcohol
withdrawal

predict SAWS with high
sensitivity.
The makers were
identified individually,
but not studied as
individual predictors of
SAWS.
The reliance on ICD-10
codes for a number of
predictive factors is
problematic for
reliability.
The AWTT could be
useful as part of a
standardized admission
protocol, but not as a
stand-alone tool for the
prediction of risk for
SAWS
The PAWSS showed
good inter-rater
reliability (CI of .936)
indicating moderate to
substantial agreement
With a cut off score or
4: PAWSS has 93.1%
sensitivity (95%CI)
99.5% specificity (95%
CI)
Positive Predictive
Validity of 93.1%
(95%CI)
Negative Predictive
Validity of 99.5%
(95%CI)
With a PPV of 79% and
a NPV of 88% the
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Withdrawal Severity Scale (Poster). Cooper
Medical School of Rowan University Capstone
Projects. 18.
https://rdw.rowan.edu/cmsru_capstones/18
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Level II

questionnaire to adults 18
and older admitted to ED
and Trauma admitting

symptoms
were
measured
and
documented
using the
Glasgow
Modified
Alcohol
Withdrawal
Scale
(GMAWS)
within 48
hours of
admission

PAWSS can be used as
an effective tool to
predict alcohol
withdrawal but it is
important to be aware of
its limitations and how it
can be further improved
The GMAWS itself does
not account for all the
symptoms of AWS, such
as autonomic instability,
and possess subjective
categories such as
anxiousness

A positive
PAWSS was
considered a
score of 4 or
greater.
Patients were
considered to
have
undergone
alcohol
withdrawal if
they had
AWS as a
primary
diagnosis or
they scored a
2 or greater
on the
GMAWS

Legend: John Hopkins Rating Hierarchy for Level of Research Evidence of Level I, Level II, Level III. AWS is Alcohol Withdrawal Syndrome. CI is
Confidence Interval. PPV is Positive Predictive Validity. NPI is Negative Predictive Validity.
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Appendix B
Summary of Systematic Reviews (SR)
Citation

Quality
Grade

Goodson, C. M., Clark, B. J., Level II
& Douglas, I. S. (2014).
Predictors of severe Alcohol
Withdrawal Syndrome: A
systematic review and meta‐
analysis. Alcoholism:
Clinical and Experimental
Research, 38(10), 2664–
2677.
https://doi.org/10.1111/acer.1
2529

Holleck, J. L., Merchant, N., Level I
& Gunderson, C. G. (2019).
Symptom-triggered therapy
for Alcohol Withdrawal
Syndrome: A systematic
review and meta-analysis of

Question

Search
Strategy

Inclusion/
Exclusion
Criteria
Can a review and A systematic
Inclusion:
synthesis of the literature search epidemiologic
existing
was conducted a studies of Alcohol
published
MeSH search in Withdrawal
literature
OVID using the Syndrome (AWS)
reporting risk
terms
published in
factors for
“substance
English
Severe Alcohol withdrawal
Withdrawal
syndrome”
Exclusion:
(SAWS) help us limited to
Articles not
better understand “alcohol” and including primary
the strength of excluding non- data regarding
evidence for
English
baseline
predictive risk language and characteristics of
measures?
non-human
inpatients with
subjects
AWS, articles
with lack of
standard
definition of
AWS, articles
with number of
patients not
reported or ranges
of potential
predictor variable
were missing

Data Extraction and
Analysis

Key Findings

Usefulness/Recom
mendation/
Implications
17 studies were included The prediction of
The findings
for qualitative review
SAWS is highly
support that prior
with 15 reporting
variable, with few
studies have failed
primary findings with
demographic, clinical to identify reliable
sufficient detail for
or biochemical
risk prediction score
meta-analysis
parameter are
for SAWS.
consistently
A meta-analysis was
predictive of SAWS No single variable
conducted of
episodes.
is sufficient to
demographic and
predict SAWS
comorbid variables
Previous experience
related to AWS
of SAWS was a
predictor of future
Most studies were
incidence of AWS
retrospective design
Some findings
There was evidence of contradict the
systematic bias as
“kindling” theory of
indicated by the
withdrawal
asymmetry of funnel
plots

Is symptomtriggered therapy
rather than fixed
does therapy
superior in terms
of mortality,

A systematic
Inclusion:
literature search Randomized
using Medline, controlled studies
Embase, and the for management
Cochrane
of AWS with
Registry from benzodiazapines

Data was collected with
a standardized form.
Methodological quality
was assessed with
Cochrane Risk of Bias
Tool. The research was

For major outcomes
of mortality, seizures
and delirium there
were to few events in
the review for

Continual
monitoring with a
monitoring tool like
the CIWA-Ar
allows for
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Citation

Quality
Grade

randomized controlled
trials. Journal of General
Internal Medicine, 34(6),
1018.
https://doi.org/10.1007/s1160
6-019-04899-7

Maldonado, J. R., Sher, Y., Level II
Ashouri, J. F., Hills-Evans,
K., Swendsen, H., Lolak, S.,
& Miller, A. C. (2014). The
“Prediction of Alcohol
Withdrawal Severity Scale”
(PAWSS): Systematic
literature review and pilot
study of a new scale for the
prediction of complicated
Alcohol Withdrawal
Syndrome. Alcohol, 48(4),
375–390.
https://doi.org/10.1016/j.alco
hol.2014.01.004
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Question

delirium,
seizures, total
benzodiazepine
dose and
duration of
therapy to treat
AWS.

Search
Strategy

database
inception
through
February 12,
2018, was
conducted for
randomized
controlled trials
of patients with
Alcohol
Withdrawal
Syndrome
comparing
fixed-dose
benzodiazepine
schedules to
symptomtriggered
therapy.
Is there a
Using PRISMA
validated
guidelines, a
screening tool to systematic
detect risk for
literature search
developing AWS was conducted
in medically ill with four
patients to allow electronic
for timely
databases:
prophylaxis
Cochrane
measures?
Database of
Systematic
And what factors Reviews,
can be identified PubMed,
in the literature PsychInfo, and
that predisposes MEDLINE,
a person to
from January
develop AWS
1966 for
January 2011,
for factors

Inclusion/
Exclusion
Criteria
comparing fixeddose schedules to
symptom driven
therapy

Data Extraction and
Analysis

Key Findings

graded by Agency for
Healthcare Research and
Quality (AHRQ)
recommendations.

Excluded:
Observational
studies

For dichotomous
outcomes, odds ratios
were calculated. For
continuous variables,
means and standard
deviations were
calculated.

meaningful
comparison.
Total benzodiazepine
dose and duration of
therapy where
statistically
significantly less in
the symptomtriggered therapy
compared to the
fixed-dose.

Usefulness/Recom
mendation/
Implications
symptom-triggered
therapy of AWS.
Symptom triggered
therapy uses less
benzodiazepine
medication and has
less duration of
therapy than fixeddose approach

6 manuscripts were
included in the review

Inclusion: Articles Data extraction from the
related to AWS, literature review yielded
dealing with
a threshold criterion of
human subjects 18 alcohol withdrawal
years or older,
consumption within the
manuscripts
last 30 days, and 10
directly dealing other predictive risk
with AWS or its characteristics to
predisposing
construct the PAWSS.
factors, case
reports,
The data was used to
naturalistic case construct a tool and a
descriptions and pilot study to test for the
all types of
predictive validity of the
clinical trials,
tool
animal data that
directly dealt with
variables

The PAWSS tool was The development of
able to demonstrate the PAWSS was
100% predictive
based on an
validity in the pilot extensive literature
study of severe AWS review.
The limitations of the The pilot study
study included the
showed good
PAWSS reliance on predictive validity
patient self-report,
but needs further
the tool needs further study to validate
validation through a findings through
larger trial with
larger sample size
larger sample size
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Citation

Quality
Grade

Pribék, I. K., Kovács, I.,
Level I
Kádár, B. K., Kovács, C. S.,
Richman, M. J., Janka, Z.,
Andó, B., & Lázár, B. A.
(2021). Evaluation of the
course and treatment of
Alcohol Withdrawal
Syndrome with the Clinical
Institute Withdrawal
Assessment for Alcohol –
Revised: A systematic
review-based metaanalysis. Drug and Alcohol
Dependence, 220.
https://doi.org/10.1016/j.drug
alcdep.2021.108536
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Question

To assess
whether the
CIWA-Ar is
suitable for
following the
course of AWS
during
pharmacotherape
utic treatment,
and to compare
Benzodiazepine
and FDAapproved nonbenzodiazepine
treatments in
patients with
AWS.

Search
Strategy

Inclusion/
Data Extraction and
Key Findings
Exclusion
Analysis
Criteria
associated with described in
the
humans
development of
AWS
Excluded:
Articles not
related directly to
AWS or its
predisposing
characteristics.
Articles primarly
done with animals
and not directly
related to
variables
described in
humans
Three authors Inclusion: Articles 11 studies were
The results showed a
independently documenting the incorporated in the meta- significant decrease
systematically severity of AWS regression and the final of CIWA-Ar total
searched four with the CIWA- unit of data analysis was scores in the course
databases
Ar in patients with the comparison of the
of AWS indicating
(PubMed,
AWS
cumulative mean
that this tool
ScienceDirect,
CIWAAr total scores of appropriately
Web of Science Exclusion:
the two phases of the
followed the course
and Cochrane Non-English
course of AWS.
of AWS (as a means
Registry) in
articles, Grey
of the ecological
order to identify literature,
There was no
validity of this
studies
publications not statistically significant measure).
published
connected to
difference between
Furthermore, the
before January AWS, articles
decrease in CIWA-Ar
group receiving
31, 2020, which with specific
scores the
benzodiazapine
documented the populations,
Benzodiazapine group treatment did not
severity of
articles with
and the nonshow a significant
AWS with the modified versions benzodiazapine group
difference from the
CIWA-Ar in
of CIWA.
non-benzodiazapine
patients treated
group from the
with AWS
Also excluded
perspective of the
were articles with
course of AWS

Usefulness/Recom
mendation/
Implications

The systematic
review supports the
use of CIWA-Ar for
monitoring of AWS
for both
benzodiazapine
based treatments
and nonbenzodiazapine
treatment.
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Quality
Grade
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Question

Search
Strategy

Inclusion/
Data Extraction and
Exclusion
Analysis
Criteria
lack of CIWA-Ar
means or standard
deviations, articles
with only baseline
CIWA-Ar score
(non-monitoring),
and non-eligible
medications

Key Findings

Usefulness/Recom
mendation/
Implications

measured by the
CIWA-Ar total
scores

Legend: John Hopkins Rating Hierarchy for Level of Research Evidence Level I, Level II or Level III. AWS is Alcohol Withdrawal Syndrome.
MeSH is Medical Subject Heading. CIWA-Ar is the Clinical Institute Withdrawal Assessment for Alcohol-Revised.
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Appendix C
SWOT Analysis for the Healthcare Organization
Strengths
• High patient volumes
• Good community reputation
• Magnet Status and emphasis on nurse driven practice change
• Strong leadership/stakeholder buy-in for practice change
• Alcohol Withdrawal order set already in place in the EMR to
address AWS when identified
• Healthcare organization does have residential and out-patient
Substance Use Disorder treatment programs already available
for privately insured persons
Opportunities
• PAWSS assessment for predictive risk assessment
• Affordable Care Act integrated Substance Use Disorders as
medical conditions covered by health insurance under the
Mental Health Parity and Addiction Equity Act (MHPAEA) and
the Affordable Care Act.
• No hospital currently identifies as a provider for alcohol
detoxification services

Weakness
• Limited to paper assessment rather than integration into EMR
• Staff burn-out, exhaustion post-COVID
• NOC shift resistance to process change
• Internal staff bias with AUD treatment

Threats
• External community bias effecting chronic underfunding of SUD
treatment
• Higher percentage of persons needing SUD treatment with lower
socio-economic status, unfunded or underinsured population
• Inconsistence reimbursement practices from private insurance
for SUD treatment
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Appendix D
Project Timeline

Complete an
organizational assessment
to determine needs
Identify area of need for
Evidence-Based Practice
Change Project
Substantiate the need for
change with relevant
evidence and statistical
support and the state,
local community and
individual hospital level
Complete literature
review based on PICOT
question
Operationally define
components of the PICOT
question
Review hospital EBP
change protocols for
necessary components
needed for eventual
approval
Gain initial support from
preceptor for project

X

X

X

X

X

X

X

X

X

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7802

Week 5

Week 3

Week 1

Activity

NUR7801
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Complete a Practice
Change Project Proposal
Present project proposal
to DNP preceptor for
feedback
Revise project proposal
based on preceptor
feedback
Identify potential agency
sources to assist with data
collection to substantiate
need
Meet with the Unit
Manager for stakeholder
buy-in and review
potential proposal
features to gauge support
Submit Project Proposal to
University Faculty to
approval

Submit Project Proposal
to EPRC for approval
Revise Proposal as
needed to gain EPRC
approval
Submit EPRC approval
and facility documents
to IIIC for facility
approval

X

X

X

X

X
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7802

Week 5

Week 3

Week 1

Activity

NUR7801
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CNO/Unit Director
approval for project
proposal and budget
With facility approval
meet with the unit
educators to present
PAWSS assessment tool
and schedule trainings for
acute care nursing staff
Collect pre-intervention
data for alcohol
withdrawal rates in the
acute care floor for 8
week period prior to
intervention start date
Review PAWSS and
Education material with
the unit nurse educators
and front line-staff
Implement the PAWSS risk
assessment screening tool
Supervise Observation
Audits with the nurse
educators to assure
completion of tool and
fidelity to the tool
Re-educate unit staff as
needed to address any
fidelity issues

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X
X

X

X

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7802

Week 5

Week 3

Week 1

Activity

NUR7801
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Weekly check of chart
audits to assure
compliance with
completions of the PAWSS
Collect intervention data
for PAWSS and outcome
measures for eight week
intervention period
Compile results of data
collected
Analyze data with
statistical software
Generate statistical
analysis of findings to
support clinical
significance
Write up findings and
outcome of practice
change
Present finding to
preceptor for feedback
Revise with preceptor’s
feedback
Submit results and final
EBP change results to the
university faculty
Present findings to key
stakeholders including
Director, CNO, Unit

X

X

X

X

X

X

X

X

X

X

X

X

X
X

X

X

X

X

X
X

X
X

X

X

X

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7802

Week 5

Week 3

Week 1

Activity

NUR7801

Manager, Preceptor, unit
staff and IIIC
Submit findings for
publication or poster
presentation
X
X

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

NUR7802

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

NUR7801

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

Week 1

Activity
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NUR7803

X
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Appendix E
Data Variable Descriptions

Variable
Name

Variable
Description

Number of
patients
admitted

Total
number of
patients
admitted to
the unit

Blood
Alcohol
Result

Results of
Blood
Alcohol
Screen

Population

AWS Time
interval

Possible Range
of Values

EMR

Any numerical
value

EMR

0-700, absent
results recorded
as missing data

Level of
Measurement

Time Frame
for
Collection

Numerical

Duration of
the
intervention

Ratio

Duration of
stay in
hospital

The time
EMR
interval from
admission to
the AW
order set
order

Any numerical
value

Interval

Duration of
stay in
hospital

Completion
of the
PAWSS

Paper
form

1=yes

Nominal

Onset of
intervention

PAWSS
Score

Documented
score from
the PAWSS

Paper
form

0-10

Ratio

Onset of
intervention

Rapid
Response

Rapid
Response
occurrence

EMR

1=yes

Nominal

Duration of
stay in the
hospital

Change in
level of
care

Patient
transfer to
higher level
of care

EMR

Nominal

Duration of
stay in the
hospital

Intervention PAWSS
tool
completed

Outcome

Data
Source

0=no

0=no
1=yes
0=no
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Code green The number
events
of times
security is
called to
respond
patients
screening
positive on
PAWSS

Security
staff
event
log

0-200

Ratio

Duration of
stay in the
hospital

CIWA-Ar
Score-Min

The
minimum
CIWA-Ar
assessment
score
recorded

EMR

0-67

Ratio

From
initiation
until
assessment
is
discontinued

CIWA-Ar
Score_Max

The
maximum
CIWA-Ar
assessment
score
recorded

EMR

0-67

Ratio

From
initiation
until
assessment
is
discontinued

Length of
stay

Total time
from
admission to
discharge in
hours

EMR

0-10,000

Ratio

From time of
admission to
time of
discharge
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Appendix F
Data Collection Sheet

Subject
ID #

BAL
result

PAWSS
tool
completed

PAWSS
tool
score

Rapid
Response
Occurrence

Change
in
Level
of Care

CIWA-Ar
Minimum

CIWA-Ar
Maximum

Time
Interval
of AW
order
set

Code
green
event

Length
of
Stay
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Appendix G
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Appendix H
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Note.Adapted from Sullivan, J.T., Skora, K., Schneiderman, J., Naranjo, C. L. & Sellers, E.M. (1989). Assessment of
Alcohol Withdrawal: The revised clinical insititute withdrawal assessment for alcohol scale (CIWA-Ar). Society for
the Study of Addiction. https://doi.org/10.1111/j.1360-0443.1989.tb00737.x
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Appendix I
Project Goals and Implementation Strategy
Project Stage
PreIntervention

PreIntervention
PreIntervention

PreIntervention

Goal or task to accomplish
Complete Organization assessment, SWOT
analysis, PICOT question and literature review
• The organizational assessment will
help identify area of opportunity and
leadership styles to consider for
change theory
• The SWOT analysis will help to identify
additional areas of opportunity with
the agency and the key stakeholders
• The PICOT question will help drive a
focused literature review for current
evidence-based practice
Complete Project Proposal, incorporating
Evidence-Based Practice Recommendation
Identify key stakeholders within the
organization and develop working relationship
• Relationships with key stakeholders
will need to be fostered for
organizational buy-in
Identify facility process for EBP project
approval
• Review both process and
organizational requirements for
project approval

Timeframe
Within the 12 weeks
prior to submitting a
project proposal

Who is responsible
DNP student with
input from agency
preceptor and USA
facility

Within the 12 weeks
prior to submitting a
project proposal
Within the 12 weeks
prior to submitting a
project proposal

DNP Student

Within the 12 weeks
prior to submitting a
project proposal

DNP Student

DNP Student

Barriers to overcome
COVID-19 restrictions
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PreIntervention

PreIntervention

Develop key educational concepts to help staff
understand and implement PAWSS and
organize an educational outline of key
concepts
• Although the project is not based on
education, it will be important for
general compliance and fidelity to
provide staff education on key
concepts of the PAWSS and overview
of AWS
Submit the proposal the USA EPRC for
Approval

EBP Project
Gain USA and facility project approval
Implementation
EBP Project
Meet with the Unit Manager for final overview
Implementation of the project implementation and education
materials
EBP Project
Meet with the Unit Educators to review outline
Implementation of Education Materials (see education outline,
Appendix J)
EBP Project
Begin education of the staff with roll out of
Implementation education materials “elevator speech” at the
daily huddle on the unit with Charge Nurse and
Nurse Manager
• The DNP student will attend daily
huddles with a short “elevator speech”
to outline the EBP project

56

Within first week of
NUR7802

DNP Student

During the first three
weeks of NUR7802,
prior to project
implementation
Within the first 4
weeks for NUR7802

DNP Student

Request for modification
of proposal

DNP student, EPRC,
facility IRB board

Any requests for
modification of the
proposal

Within the 5th week
of NUR7802

DNP student

Within the 5th week
of NUR7802

DNP student

Within the 5th week
of NUR7802

DNP Student, CNS
educators, Charge
Nurse
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•

EBP Project
Implementation

EBP Project
Implementation

EBP Project
Implementation
EBP Project
Implementation

The Charge nurse will communicate
the practice change in the shift report
to all on-coming staff
Unit CNS educating floor staff on the PAWSS
• The CNS educators will highlight the
practice change within their “poster
presentation area” on the unit where
they normally highlight best practices
for the unit. The CNS will also work
with each staff on the unit
approximately 5 minutes to review the
PAWSS tool and see a return
demonstration of the staff
administering the tool
Provide staff access to written education
materials outlining the PAWSS and current
practices for treatment of AWS for reference
• The unit staff will be provided with an
electronic link to a recorded
educational presentation on the
administration of the PAWSS tool and
a general overview of AWS
management. This will be prepared by
the DNP student with input from the
CNS
Prepare copies of the PAWSS for use on the
unit
Begin implementing the PAWSS assessment for
all patient admitted to the unit

Within the 5th week
of NUR 7802

CNS Nurse Educator

Within the 5th week
of NUR7802

DNP Student and CNS
Nurse Educator

Within the 5th week
of NUR7802
Week 6 of NUR7802

DNP Student

none

Unit nursing staff

Staff buy-in. Time
management with
assessments. Compliance
with the new procedure.
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•

The paper tool will be completed by
the bedside RN with each patient
admitted to the unit.
• Nursing staff will be directed to record
positive scores (≥4) in the nursing
interdisciplinary note in the EMR and
to notify the attending physician
according to the standard process
when there is a need for additional
orders
• The completed PAWSS tool will be
collected in a folder in the charge
nurse office, not viewable to the
public, and stored in accordance with
all HIPAA compliance measures to
protect health information
EBP Project
Collect pre-intervention data for a period of 8
Implementation weeks prior to implementation
• The EMR will be accessed for data
collection as well as the security safety
logs for the unit for the 8 weeks prior
to project implementation.
EBP Project
Supervise Observation Audits with the CNS
Implementation nurse educators to assure completion of tool
and fidelity to the tool.
• The CNS will complete a minimum of 7
audits per week during the first week,
each of different staff, to ensure
compliance and fidelity to the tool
• Audits will be repeated at the third
week and then at the 5th week, to

COVID restrictions
Staffing challenges
Lack of appropriate
medications (nation wide
Librium shortage)

After gaining facility
IRB approval for EMR
access

DNP Student

Week 6-14 of
NUR7802. These
audits will happen
weekly

CNS Nurse Educator
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verify compliance and fidelity to the
tool.
• The audit will consist of the CNS
verifying that for a random patient
admission that the PAWSS tool was
completed and there is documentation
of physician notification in the EMR for
scores ≥4. This information will be
recorded on a checklist on the front
inside cover of the PAWSS collection
folder in the nursing office
EBP Project
Collect intervention data for PAWSS and
Implementation outcome measures for eight week intervention
period (see data sheet in Appendix F)
PostCompile results of data collected and perform
Intervention
statistical analysis
• Using the results collected in the date
sheet, the data will be entered into the
Intellectus Statistic software for data
analysis
PostAnalyze findings and complete write up of the
Intervention
analysis and outcomes from the practice
change with feedback from USA faculty advisor
and DNP preceptor
PostFinally, the results and clinical significance will
Intervention
be synthesized and disseminated to the key
stakeholders and the larger healthcare
community
• Results and significance will be
reported back to the unit manager and
staff during the daily huddle
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Week 6-14 of
NUR7802.

DNP Student

Time management.

NUR7803 (see
timeline in Appendix
D)

DNP Student

Delays in data pull from IT
department due to
conflicting priorities

NUR7803 (see
timeline in Appendix
D)

DNP Student, USA
faculty and DNP
preceptor

NUR7803 (see
timeline in Appendix
D)

DNP student

ALCOHOL WITHDRAWAL

•
•

•

•

Results and significance will be
presented to the USA faculty of course
NUR7803
Results and significance will be
reported back to the facility
Innovations, Inquiry and Professional
Excellence Committee
Summary of results and significant will
be presented to hospital leadership
including the CEO and CNO with
recommendation for future
sustainability practices
Final results and significance will be
published in a scholarly journal to
further nursing EBP
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Appendix J
Education Material Outline
Brief Overview of the Prevalence and Impact of AWS in Acute Care Setting
Pathophysiology of Alcohol Withdrawal
• GABA and Glutamate pathways
• Wernicke’s encephalopathy and Korsakoff’s psychosis
• Complicated alcohol withdrawal
• Delirium Tremens
• Death
Overview and Demonstration of the PAWSS Assessment
• Review of Questions
• Modeling of Assessment
Overview of current Medical Management Practices
• Thiamine, Multivitamins, Folic Acid
• Magnesium
• Smoking Cessation
• Hydration (IV Fluids)
• Benzodiazepines
• Other commonly seen medications
CIWA-Ar Protocol for Monitoring
• Assessment overview and modeling to create accurate scoring
• Score and medications: lorazepam and diazepam
• Prophylaxis: Chlordiazepoxide, Gabapentin
Lab Work and Other Diagnostic Tests
Consult Social Worker, Dietician or Psychiatric Services
Non-pharmacological Interventions
• Early hydration, nutrition
• Early mobilization
• Promote circadian light rhythm, sleep hygiene
• Visitations/Intellectual Stimulation
• Seizure precautions
• Fall precautions
• Aspiration precautions
Patient/Family Education and Community Resources

